Skip to main content
. 2014 Mar 8;105(4):437–444. doi: 10.1111/cas.12361

Fig. 4.

Fig. 4

Survival analyses of the patients in MYC+ group. Overall survival (a) and progression-free survival (b) in association with BACH2 expression levels.